Skip to content

Management of Polycystic Ovarian Syndrome in young women

Effects of combined prolonged Simvastatin and Metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201710002641118
Enrollment
200
Registered
2017-09-24
Start date
2013-09-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome PCOS

Interventions

Combined Metformin and Simvastatin
Metformin

Sponsors

Emaduldin Seyam
Lead Sponsor
Minia University Obstetrics and Gynecology department
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: A randomized, double-blind controlled study was performed using combined Simvastatin and metformin with PCOS unmarried women in a tertiary care centre in Upper Egypt. The diagnosis of PCOS was based on the availability of the three diagnostic criteria of the Rotterdam consensus, namely clinical and biochemical evidence of hyperandrogenaemia (Ferriman-Gallwey score (FGS), free androgen index (FAI) respectively), oligomenorrhea or amenorrhea and polycystic ovaries on transabdominal ultrasound

Exclusion criteria

Exclusion criteria: Women recruited had no concurrent illness, and were not on any prescription or over-the-counter medication which might affect insulin sensitivity, lipids or ovarian function including hormonal contraceptives for the preceding six months. 21-hydroxylase deficiency, hyperprolactinaemia, Cushing¿s disease and androgen-secreting tumors were excluded by appropriate tests. All women were young unmarried and not planning to marry at least till the end of study period. Recruited women were advised not to change their lifestyle, including physical activity or dietary habits, during the study period

Design outcomes

Primary

MeasureTime frame
Spontaneous ovulation improvement

Secondary

MeasureTime frame
Improvement of the clinical, and biochemical abnormalities assocaited with PCOS

Countries

Egypt

Contacts

Public ContactMarwa Mohamed

Specialist in Obstetrics and Gynecology

dr_marwa_mymh@yahoo.com+201003480999

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026